ClinicalTrials.gov
ClinicalTrials.gov Menu

Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00885820
Recruitment Status : Completed
First Posted : April 22, 2009
Last Update Posted : September 18, 2014
Sponsor:
Collaborator:
Astellas Pharma Canada, Inc.
Information provided by (Responsible Party):
Astellas Pharma Inc